Sciegen Pharmaceuticals India Private Limited, a active private limited company, was established on 28 January 2013 in Serilingampally, Telangana, India. Engaging in pharma contract r&d within the professional, scientific and technical sector, it holds CIN: U24240TG2013PTC085471. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹9.00 Cr and a paid-up capital of ₹1.43 Cr.
Formerly known as Pmr Energy Private Limited. It upholds a compliant status. Employing 45 professional, Its leadership includes Saketh Reddy Pailla (Director), Venkata Siva Reddy Pallempalli (Director), Alla Bhaskara Reddy (Director). Past directors included Mohan Reddy Patalolla, Shilpasri Reddy Pailla, Bhagwant Reddy Gantla. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Plot No.238, Khanamet Village, Kondapur, K.V. Rangareddy, Serilingampally, Serilingampally, Telangana, 500084.
U24240TG2013PTC085471
085471
28 January 2013
₹9.00 Cr
₹1.43 Cr
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Sciegen Pharmaceuticals India Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Saketh Reddy Pailla | Director | 29 Apr 2023 | Current |
| Venkata Siva Reddy Pallempalli | Director | 10 Aug 2018 | Current |
| Alla Bhaskara Reddy | Director | 02 Oct 2017 | Current |
| Pailla Malla Reddy | Director | 28 Dec 2015 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 06 Feb 2016 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
| Pramod Abcsdd | Director | 06 Feb 2016 | Past |
| Pramod Abcsdd | Additional Director | 12 Sep 2018 | Past |
| Pramod Abcsdd | Director | 19 Jun 2015 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Sciegen Pharmaceuticals India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15.55% increase. The company also saw a substantial fall in profitability, with a 74.73% decrease in profit. The company's net worth Soared by an impressive increase of 276.67%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Sciegen Pharmaceuticals India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Sciegen Pharmaceuticals India has a workforce of 45 employees as of Oct 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Sciegen Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sciegen Pharmaceuticals India's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Sciegen Pharmaceuticals India Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Sciegen Pharmaceuticals India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was documented.
Saketh Reddy Pailla was appointed as a Director was appointed as a Director on 29 Apr 2023 & has been associated with this company since 2 years 7 months . was recorded as a recent event.
The activity Venkata Siva Reddy Pallempalli was appointed as a Director was appointed as a Director on 10 Aug 2018 & has been associated with this company since 7 years 3 months . was completed.
The activity Alla Bhaskara Reddy was appointed as a Director was appointed as a Director on 02 Oct 2017 & has been associated with this company since 8 years 2 months . was completed.
Pailla Malla Reddy was appointed as a Director was appointed as a Director on 28 Dec 2015 & has been associated with this company since 9 years 11 months . was recorded as a recent event.
The CIN of Sciegen Pharmaceuticals India Private Limited is U24240TG2013PTC085471.
Sciegen Pharmaceuticals India Private Limited is headquartered at Plot No.238, Khanamet Village, Kondapur, K.V. Rangareddy, Serilingampally, Serilingampally, Telangana, 500084.
Sciegen Pharmaceuticals India Private Limited was incorporated on 28 January 2013.
The current directors of Sciegen Pharmaceuticals India Private Limited are
The primary industry of Sciegen Pharmaceuticals India Private Limited is Professional, Scientific And Technical.
Sciegen Pharmaceuticals India Private Limited is unlisted.
The authorized capital of Sciegen Pharmaceuticals India Private Limited is ₹9.00 Cr, and the paid-up capital is ₹1.43 Cr.
The compliance status of Sciegen Pharmaceuticals India Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX